Near Fatal Asthma in Children and Young People
1 other identifier
observational
400
1 country
1
Brief Summary
This study will report the frequency, risks factors, clinical care and estimate the future asthma risk of children and young people (aged 5-15 years) experiencing a Delphi defined near fatal asthma (NFA) attacks in the United Kingdom (UK) and Republic of Ireland (ROI). A greater understanding of the frequency and risk factors associated with NFA could help support children and young people (CYP), parents and clinicians to identify and modify risk, both independently and through a resulting clinical care pathway and also develop future research to improve effectiveness of interventions. The study will explore both commonly identified clinical factors, but also for the first time describe in detail the variance in medical management (acute and intensive care) that could lead to future clinical trials and guideline development to standardise care. The study will also describe, through data-linkage, socio-demographic factors associated with NFA, to include pollution, pollen, weather, viral prevalence that could lead to better care for higher risk CYP. To encourage more consistent, less fragmented care following a near fatal asthma attack, the study will consider how care is provided subsequent to an NFA attack using British Paediatric Surveillance Unit (BPSU) surveillance at 12 and 24 month follow up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 25, 2022
CompletedStudy Start
First participant enrolled
October 31, 2022
CompletedFirst Posted
Study publicly available on registry
November 30, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2026
CompletedJune 27, 2025
June 1, 2025
3.5 years
October 25, 2022
June 23, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Number of cases of Near Fatal Asthma reported to British Paediatric Surveillance Unit
Descriptive data
18 months
Secondary Outcomes (3)
Detailed analysis of the clinical, social and environmental characteristics of those who experience NFA.
18 months
Detailed analysis of the care provided to CYP who experience NFA at the time of the event, during emergency, in patient and critical care.
18 months
Reporting of the 12 and 24 months following an episode of NFA, estimating the future risk of a health-related asthma event and the healthcare that is provided to those experiencing NFA.
42 months
Interventions
Observational surveillance study
Eligibility Criteria
The number of children and young people identified who experience NFA within the 18-month surveillance period is not known, but is estimated to be c400 (from paediatric intensive care admission data). All UK and ROI hospitals where children may attend with acute asthma could be potential contributing sites. Each case will be followed up for 24 months following the near fatal asthma event.
You may qualify if:
- A child/young person is considered to have experienced an episode of near fatal asthma if they meeting any one of the following:
- Any child aged 5-15 years surviving\* an acute episode of asthma, who when presenting self-ventilating with severe dyspnoea (e.g. inability to speak) and all the following features:
- Pulse oxygen saturation below 92% despite maximal oxygen therapy (i.e. 10-15l/min oxygen flow via non-rebreather mask) during acute presentation
- pH \<= 7.2 and/or pCO2 \>=60mmHg or 8kPa
- Escalation to use of intravenous bronchodilator infusion
- Any child aged 5-15 years surviving\* an acute episode of asthma, who had a respiratory arrest and/or required cardiopulmonary resuscitation as part of their presentation.
- Any child age 5-15 years surviving\* an acute episode of asthma for which he/she was invasively ventilated.
- surviving to hospital discharge
You may not qualify if:
- CYP not meeting the case definition will be excluded. An expert panel (consisting of three clinicians) will adjudicate borderline cases.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Edinburgh
Edinburgh, United Kingdom
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 25, 2022
First Posted
November 30, 2022
Study Start
October 31, 2022
Primary Completion
April 30, 2026
Study Completion
April 30, 2026
Last Updated
June 27, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share